SRPT vs TERN · rev $1.90B vs $6.12B cap
Sarepta Therapeutics Inc (SRPT) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
SRPT currently screens at market cap $2.34B. TERN currently screens at market cap $6.12B.
Not investment advice. Open the SRPT and TERN stock pages for the full models.
Not investment advice.